# To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.

> **NCT01951599** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 35 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD9291
- **DRUG:** AZD9291
- **DRUG:** AZD9291
- **DRUG:** AZD9291
- **DRUG:** AZD9291

## Key facts

- **NCT ID:** NCT01951599
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-09
- **Primary completion:** 2014-06-04
- **Final completion:** 2014-06-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951599, "To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01951599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*